Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Population modeling 1204 INDEX

Table 1. The 72-atom model examined by different theoretical methods. The energy differences (AE in kcal/mol) are calculated with respect to the lowest SCF energy. q(Fe) stands for Mulliken population charges on the Fe atoms q(S) and SS(b.i.) are the Mulliken population charges and the bond index for the bridging S atoms, respectively AEq is the calculated Mossbauer quadrupole splitting constant [mm/sec]. The PUHF spin states are those projected from the UHF wavefunction with 5 = 5,. [Pg.363]

In Section 3.1., we shall show that the dynamic model leads to an unambiguous determination of the type of nonbonded interactions involved while the static model may lead to erroneous predictions as a result of an ambiguous definition of the nature of a nonbonded interaction. The superiority of the dynamic model is due to the fact that nonbonded interactions affect bonded interactions and, thus, the change in an overall overlap population rather than the change of a specific overlap population between nonbonded atoms or groups is the most appropriate index of a nonbonded interaction. Accordingly, we shall employ the dynamic model in all subsequent discussions of molecular structure, unless otherwise stated. [Pg.46]

Which approach to model reduction is the most important Population is not the ultimate judge, and popularity is not a scientific criterion, but "Vox populi, vox Dei", especially in the epoch of citation indexes, impact factors and bibliometrics. Let us ask Google. It gave on 31st December 2006 ... [Pg.105]

Figure 5.9. Dose-response profile in a population. (A) Relationship between responding patients, expressed as percentage of individuals, and plasma drug concentrations. With increasing drug concentration, the proportion of patients who derive therapeutic benefit, without concentration-limited side effect peaks, and then declines. (B) A schematic representation of dose-response curves. Typical therapeutic and lethal responses at indicated doses are evaluated in animal models to estimate therapeutic index, TI. ED50, effective dose needed to produce a therapeutic response in 50% of animals, exhibiting therapeutic response LD50, effective dose needed to produce lethal effects in 50% of animals. Figure 5.9. Dose-response profile in a population. (A) Relationship between responding patients, expressed as percentage of individuals, and plasma drug concentrations. With increasing drug concentration, the proportion of patients who derive therapeutic benefit, without concentration-limited side effect peaks, and then declines. (B) A schematic representation of dose-response curves. Typical therapeutic and lethal responses at indicated doses are evaluated in animal models to estimate therapeutic index, TI. ED50, effective dose needed to produce a therapeutic response in 50% of animals, exhibiting therapeutic response LD50, effective dose needed to produce lethal effects in 50% of animals.
Total intakes of OCPs from the Australian diet and environment have been estimated from the 1970s to the 1990s and used to evaluate human health risks for the Australian population. The Hazard Index (HI) was estimated for the general Australian population for the OCPs for 1996 at <1.0 in all cases. In addition, the USA-EPA model for occurrence of cancer has been applied to some of the persistent OCPs and found to be in the range of >1 x 10-6 to 4 x 10-5. The level of health risk for the general Australian population was considered to be acceptable in 1996. [Pg.753]

Products that may have the potential to stimulate growth or induce proliferation or clonal expansion of cell types, in particular, transformed cells, all processes that may eventually lead to neoplasia should be evaluated with respect to receptor expression in various malignant and normal human cells that are relevant to the patient population under study [27], In such cases normal human cell lines and multiple human cancer cell lines expressing the relevant receptor, as well as primary cells derived from human tumor explants, should be used for in vitro assessment. When in vitro data demonstrate enhanced growth, further studies in relevant in vivo xenograft animal models with receptor expressing tumor cell lines may be needed. In addition incorporation of sensitive indexes of cellular proliferation in long-term repeat-dose toxicity studies may provide useful information. [Pg.413]

Following a similar approach but using a smaller data set of 369 compounds, Ivanciuc et al. correlated their liquid viscosity (10 Pa s) at 298 K with a mixed set of descriptors to obtain Eq. [48]. This involves three QM descriptors, one topological, and one constitutional descriptor. The QM descriptors were calculated with the AMI Hamiltonian in AMPAC, and CODESSA was used to calculate the descriptors and perform the statistical analyses. The HDCA2 parameter is the same HBD charged surface area used in Eq. [46]. The maximum electrophilic reactivity index, Ep, for a carbon atom is defined by X/ lumo,/A lumo+ 10), with the summation over the valence AOs on a carbon atom in the LUMO. The maximum AO electronic population, Y, models the molecular nucleophilicity and is defined by... [Pg.248]

Vicinity index. One such measure of separation is based on an exact upper bound for two-electron integrals of model wavefunctions which remains almost always valid for realistic LCAO orbitals, as well. The vicinity index [30, 31] of two MOs (pi and (pj fits well into framework of population localization, as it uses the atomic population definitions QlA and QJA of the orbitals defined by (14). The quantity... [Pg.55]

Recording details of the studies, including the models used and associated parameter values reported, is an obvious starting place. Additional details include the chemical analysis method, the pharmacokinetic analysis method, the studied population (specifically subpopulations), number of healthy volunteers or patients, number of pharmacokinetic samples per patient, the dose, the formulation, and the route of administration. If one publication includes several groups of patients (or the same patient received two different formulations/concomitant medications), then each cohort may need to be treated as a repeated measure of the same study or within the same study, which may be indexed according to a study or patient covariate. [Pg.149]


See other pages where Population modeling 1204 INDEX is mentioned: [Pg.266]    [Pg.391]    [Pg.200]    [Pg.337]    [Pg.1079]    [Pg.288]    [Pg.364]    [Pg.291]    [Pg.46]    [Pg.46]    [Pg.355]    [Pg.697]    [Pg.697]    [Pg.423]    [Pg.254]    [Pg.362]    [Pg.436]    [Pg.256]    [Pg.268]    [Pg.581]    [Pg.58]    [Pg.81]    [Pg.227]    [Pg.309]    [Pg.253]    [Pg.596]    [Pg.655]    [Pg.21]    [Pg.309]    [Pg.444]    [Pg.851]    [Pg.58]    [Pg.3254]    [Pg.3255]    [Pg.2810]    [Pg.2812]    [Pg.1199]    [Pg.61]    [Pg.217]    [Pg.221]    [Pg.172]   


SEARCH



INDEX model

INDEX modeling

Model population

Population modeling

© 2024 chempedia.info